Keyphrases
Randomized Controlled Trial
100%
Foley Balloon
100%
Dilapan
100%
Outpatient Cervical Ripening
100%
Vaginal Delivery
36%
Between-group
18%
Non-inferiority
18%
Pregnant Women
9%
Confidence Interval
9%
Patient Satisfaction
9%
Body Mass Index
9%
Cervical Ripening
9%
Cervix
9%
Clinical Providers
9%
Dilator
9%
Adverse Events
9%
Daily Activities
9%
Unfavorable Cervix
9%
Per Protocol
9%
Protrusion
9%
Absolute Difference
9%
Interaction Analysis
9%
Intent-to-treat Analysis
9%
Cervical Dilation
9%
Pre-induction
9%
Satisfaction Survey
9%
Estimated Frequency
9%
Noninferiority Margin
9%
Safe Profile
9%
Introitus
9%
Medicine and Dentistry
Uterine Cervix Ripening
100%
Randomized Controlled Trial
100%
Dilapan
100%
Vaginal Delivery
36%
Analysis
18%
Patient
18%
Woman
18%
Cervix
18%
Study Design
9%
Sleep
9%
Adverse Event
9%
Sodium Chloride
9%
Satisfaction
9%
Body Mass Index
9%
Parity
9%
Patient Satisfaction
9%
Intention-to-Treat Analysis
9%
Cervical Dilation
9%
Introitus
9%
INIS
balloons
100%
ripening
100%
delivery
36%
patients
27%
women
18%
margins
18%
hypothesis
9%
management
9%
interactions
9%
power
9%
populations
9%
size
9%
design
9%
comparative evaluations
9%
induction
9%
performance
9%
surveys
9%
sleep
9%
devices
9%
parity
9%
food and drug administration
9%